Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Comprehensive Loss

v3.23.2
Condensed Consolidated Statements Of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sales        
Sales $ 83,728 $ 114,933 $ 181,112 $ 228,209
Cost of goods sold 52,974 71,251 114,337 140,275
Gross profit 30,754 43,682 66,775 87,934
Operating expenses        
Selling, general and administrative 30,200 35,444 63,019 69,619
Restructuring charges 736   736  
Transaction costs 59 821 133 2,022
Contingent consideration (benefit) expense   (374) (1,565) 389
Total operating expenses 30,995 35,891 62,323 72,030
Operating (loss) income (241) 7,791 4,452 15,904
Other income (expense)        
Interest expense, net (2,857) (1,728) (5,603) (2,844)
Other, net 224 (1,343) 309 (1,410)
Total other expense, net (2,633) (3,071) (5,294) (4,254)
(Loss) income before income tax (2,874) 4,720 (842) 11,650
Income tax (benefit) expense (783) 956 (349) 2,577
Net (loss) income (2,091) 3,764 (493) 9,073
Other comprehensive loss, net of tax:        
Foreign currency translation adjustment (1,389) (17,632) (2,410) (11,555)
Unrealized gain on hedging activities 25 622 (54) 708
Other comprehensive loss (1,364) (17,010) (2,464) (10,847)
Comprehensive loss $ (3,455) $ (13,246) $ (2,957) $ (1,774)
Net (loss) income per share:        
Basic $ (0.06) $ 0.10 $ (0.01) $ 0.24
Diluted $ (0.06) $ 0.09 $ (0.01) $ 0.23
Weighted average shares outstanding:        
Basic 37,192 37,235 37,164 37,199
Diluted 37,192 39,697 37,164 39,751
Domestic Sales        
Sales        
Sales $ 46,656 $ 64,073 $ 91,572 $ 126,380
International Sales        
Sales        
Sales $ 37,072 $ 50,860 $ 89,540 $ 101,829